Share on:
Medical Metrics, a provider of imaging core lab services for orthopedic clinical trials, has been selected by five leading orthopedic device manufacturers to support multiple cross-sectional post-market FDA surveillance studies of metal-on-metal (MoM) hip implants. MMI will independently evaluate radiographs and MRI to assess long-term outcomes in patients implanted with MoM hips. Over 2,000 subjects will be evaluated at one to 10 years post-implantation.
The goal of these studies is to comply with the FDA’s 522 order requiring manufacturers of MoM hip implants to conduct clinical surveillance of the effect of device wear in implanted patients. (Source: Medical Metrics, Inc.)
RELATED ARTICLES
Norwood Medical Appoints Gregg Olson as VP Sales & Marketing
Mar 27 2024 , Julie A. Vetalice
Tapping into the Promising Potential of AI in Orthopedics
Mar 26 2024 , BONEZONE Editors
4 Benefits of Additive Manufacturing Design in the Orthopedic Market
Mar 25 2024 , Paragon Medical
Materials Solutions for Medical Device Instrumentation
Mar 22 2024 , Carpenter Technology